EPITECH GROUP SpA

Epitech Group SpA is an Italian biopharmaceutical company with over 30 years of scientific activity in the field of neuroinflammation. A pioneer in the study of ALIAmide molecules, it develops innovative approaches to modulate "according to Nature" neuroimmune mechanisms for the benefit of health. Over 400 international patents and more than 40 active research projects testify to its ongoing commitment to scientific and technological innovation, fully respecting the body's self-regulation processes.